Fig. 1.
Overall survival (OS), a according to exact primary tumor location, patients with double primary tumors and with primary tumor of left flexure were excluded due to sample size, b according to right-sided versus left-sided mCRC, c patients with KRAS codon 12/13 wild-type tumors, d patients with KRAS codon 12/13 mutant tumors